Literature DB >> 22129048

Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century.

Peter D Arkwright1, Andrew R Gennery.   

Abstract

The 10 warning signs of primary immunodeficiency are being promoted as a screening tool for use by both the general public and physicians. A recent study, however, shows that except for family history, need for intravenous antibiotics and failure to thrive, the 10 warning signs are not a useful screen of primary immunodeficiency diseases (PIDs). Over the last few decades, there has been a revolution in our understanding of PID. The 10 warning signs do not take into account the fact that PIDs now include diseases that present with sporadic infections, autoimmunity, autoinflammation, and malignancy. This review focuses on the advances in our understanding of PID, the current limitations of the 10 warning signs, and recommendations to ensure that patients with PID are diagnosed in a timely fashion in the future.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2011        PMID: 22129048     DOI: 10.1111/j.1749-6632.2011.06206.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

1.  The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules?

Authors:  Petra Lankisch; Julia Schiffner; Sujal Ghosh; Florian Babor; Arndt Borkhardt; Hans-Jürgen Laws
Journal:  J Clin Immunol       Date:  2015-03-08       Impact factor: 8.317

2.  Differing Performance of the Warning Signs for Immunodeficiency in the Diagnosis of Pediatric Versus Adult Patients in a Two-Center Tertiary Referral Population.

Authors:  Jaclyn A Bjelac; Jennifer R Yonkof; James Fernandez
Journal:  J Clin Immunol       Date:  2019-01-04       Impact factor: 8.317

3.  Primary immunodeficiency diseases worldwide: more common than generally thought.

Authors:  Ahmed Aziz Bousfiha; Leïla Jeddane; Fatima Ailal; Ibtihal Benhsaien; Nizar Mahlaoui; Jean-Laurent Casanova; Laurent Abel
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

Review 4.  How reliable is online diffusion of medical information targeting patients and families?

Authors:  Pedro Xavier-Elsas; Sandra Epifânio Bastos; Maria Ignez C Gaspar-Elsas
Journal:  World J Exp Med       Date:  2015-11-20

Review 5.  Primary immunodeficiency for the primary care provider.

Authors:  A W O'Keefe; M Halbrich; M Ben-Shoshan; C McCusker
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

6.  Patients with primary immunodeficiencies in pediatric intensive care unit: outcomes and mortality-related risk factors.

Authors:  Cağlar Odek; Tanil Kendirli; Figen Doğu; Ayhan Yaman; Göksel Vatansever; Funda Cipe; Sule Haskoloğlu; Can Ateş; Erdal Ince; Aydan Ikincioğullari
Journal:  J Clin Immunol       Date:  2014-02-09       Impact factor: 8.317

7.  Comprehensive report of primary immunodeficiency disorders from a tertiary care center in India.

Authors:  Manisha Madkaikar; Anju Mishra; Mukesh Desai; Maya Gupta; Snehal Mhatre; Kanjaksha Ghosh
Journal:  J Clin Immunol       Date:  2012-10-31       Impact factor: 8.317

Review 8.  Primary Immunodeficiencies: Diseases of Children and Adults - A Review.

Authors:  Aleksandra Lewandowicz-Uszyńska; Gerard Pasternak; Jerzy Świerkot; Katarzyna Bogunia-Kubik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two Decades.

Authors:  Saul Oswaldo Lugo Reyes; Guadalupe Ramirez-Vazquez; Alonso Cruz Hernández; Edgar A Medina-Torres; Ana Belen Ramirez-Lopez; Corín España-Cabrera; Citlali A Hernandez-Lopez; Marco A Yamazaki-Nakashimada; Francisco J Espinosa-Rosales; Sara E Espinosa-Padilla; Chiharu Murata
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

10.  Clinical predictors of primary immunodeficiency diseases in children.

Authors:  Shereen M Reda; Dalia H El-Ghoneimy; Hanaa M Afifi
Journal:  Allergy Asthma Immunol Res       Date:  2012-11-02       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.